HIGHLIGHTS
- who: Muhammad Ashar Ali et al. from the Department of Internal Medicine, StMary`s and StClare`s Hospitals, New York Medical College, Denville, NJ, USA have published the article: Safety and Efficacy of Tyrosine Kinase Inhibitors in Immune Thrombocytopenic Purpura: A Systematic Review ofClinical Trials, in the Journal: (JOURNAL) of 21/Oct/2022
- what: Fostamatinib and HMPL-523 (Syk inhibitors) were more effective than the placebo and were well tolerated by most of the patients with severe resistant ITP.
SUMMARY
ITP symptoms vary widely among cases; in general, patients with platelet . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.